Joseph Bergenstråhle

Joseph Bergenstråhle, PhD, is a Senior Analyst at Brummer & Partners since August 2022, specializing in healthcare long/short investments. Previously, Joseph served as an Investment Analyst at Sciety from October 2018 to July 2022, and as a PhD student at SciLifeLab from July 2015 to February 2021, where the doctoral thesis explored gene technology. Prior roles include a Research Engineer position at Science for Life Laboratory and a Master’s thesis at Karolinska Institutet, focusing on serotonergic neuron connectivity. Joseph's educational background includes a Master of Science in Medical Biotechnology from KTH Royal Institute of Technology, with exchange studies completed at the University of Melbourne. Early career experience includes a role as Nät-och Driftkonsult at Indtech AB.